(Q34570082)

3 August 2017

1 reference

title

Histone deacetylases and cancer: causes and therapies (English)

1 reference

3 August 2017

Marks P

1

1 reference

3 August 2017

Rifkind RA

2

1 reference

3 August 2017

Richon VM

3

1 reference

3 August 2017

Breslow R

4

1 reference

3 August 2017

Miller T

5

1 reference

3 August 2017

Kelly WK

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

3 August 2017

Nature Reviews Cancer

1 reference

3 August 2017

1

1 reference

3 August 2017

194-202

1 reference

3 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/35106079

3 August 2017

0 references

cites work

Erythroleukemic Differentiation

1 reference

7 January 2021

Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide

1 reference

7 January 2021

A new group of potent inducers of differentiation in murine erythroleukemia cells

1 reference

7 January 2021

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

1 reference

7 January 2021

Histone deacetylase inhibitors as new cancer drugs

1 reference

7 January 2021

Histone acetylation and chromatin remodeling

1 reference

7 January 2021

Histone acetylation at promoters is differentially affected by specific activators and repressors

1 reference

7 January 2021

Functional significance of histone deacetylase diversity

1 reference

7 January 2021

The human histone deacetylase family

1 reference

7 January 2021

Histone acetylation and disease

1 reference

7 January 2021

Histone deacetylases, transcriptional control, and cancer

1 reference

7 January 2021

Butyrate as a differentiating agent: pharmacokinetics, analogues and current status

1 reference

7 January 2021

Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase

1 reference

7 January 2021

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

1 reference

7 January 2021

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

1 reference

7 January 2021

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

1 reference

7 January 2021

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

1 reference

7 January 2021

Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase

1 reference

7 January 2021

Histone deacetylase: a target for antiproliferative and antiprotozoal agents

1 reference

7 January 2021

Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome

1 reference

7 January 2021

Covalent modifications of histones: expression from chromatin templates.

1 reference

7 January 2021

The language of covalent histone modifications

1 reference

7 January 2021

Histone acetyltransferases

1 reference

7 January 2021

Acetylation: a regulatory modification to rival phosphorylation?

1 reference

7 January 2021

The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases

1 reference

7 January 2021

Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins

1 reference

7 January 2021

Cloning and characterization of a histone deacetylase, HDAC9

1 reference

7 January 2021

Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras

1 reference

7 January 2021

Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases

1 reference

7 January 2021

Genomewide studies of histone deacetylase function in yeast

1 reference

7 January 2021

Yeast HOS3 forms a novel trichostatin A-insensitive homodimer with intrinsic histone deacetylase activity

1 reference

7 January 2021

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

1 reference

7 January 2021

DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters

1 reference

7 January 2021

Association of histone deacetylase with COUP-TF in tumorigenic Ad12-transformed cells and its potential role in shut-off of MHC class I transcription

1 reference

7 January 2021

Conjunction dysfunction: CBP/p300 in human disease.

1 reference

7 January 2021

Mutations truncating the EP300 acetylase in human cancers

1 reference

7 January 2021

Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome

1 reference

7 January 2021

Loss of heterozygosity on chromosome 16 in hepatocellular carcinoma

1 reference

7 January 2021

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

1 reference

7 January 2021

Role of histone deacetylases in acute leukemia.

1 reference

7 January 2021

Transcription therapy for cancer

1 reference

7 January 2021

The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.

1 reference

7 January 2021

ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex

1 reference

7 January 2021

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

1 reference

7 January 2021

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

1 reference

7 January 2021

Design and synthesis of a novel class of histone deacetylase inhibitors

1 reference

7 January 2021

The synthesis of cyclic tetrapeptoid analogues of the antiprotozoal natural product apicidin

1 reference

7 January 2021

Synthesis of apicidin-derived quinolone derivatives: parasite-selective histone deacetylase inhibitors and antiproliferative agents

1 reference

7 January 2021

In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD / Shi-scid/scid mice.

1 reference

7 January 2021

Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives

1 reference

7 January 2021

Chronic oral administration of CI-994: a phase 1 study

1 reference

7 January 2021

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

1 reference

7 January 2021

Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells

1 reference

7 January 2021

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

7 January 2021

Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects

1 reference

7 January 2021

Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function

1 reference

7 January 2021

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

1 reference

7 January 2021

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

1 reference

7 January 2021

Epigenetic regulation of gelsolin expression in human breast cancer cells

1 reference

7 January 2021

Telomerase activation by histone deacetylase inhibitor in normal cells

1 reference

7 January 2021

Histone hyperacetylation induced by histone deacetylase inhibitors is not sufficient to cause growth inhibition in human dermal fibroblasts

1 reference

7 January 2021

Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

1 reference

7 January 2021

Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors

1 reference

7 January 2021

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

7 January 2021

Isolation and characterization of mammalian HDAC10, a novel histone deacetylase

1 reference

7 January 2021

Identifiers

DOI

10.1038/35106079

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference